78
Participants
Start Date
September 30, 2014
Primary Completion Date
November 27, 2017
Study Completion Date
December 31, 2021
CF102
orally q12h
Placebo
orally q12 hours
Simmons Cancer Center, Dallas
University of Colorado Cancer Center, Aurora
Complex Oncology Center - Plovdiv, Plovdiv
Multiprofile Hospital for Active Treatment Central Onco Hospita, Plovdiv
"Multiprofile Hospital for Active Treatment Tokuda Hospital Sofia AD", Sofia
Multiprofile Hospital for Active Treatment for women's health - Nadezhda, Sofia
Multiprofile Hospital for Active Treatment Serdica, Sofia
"Multiprofile Hospital for Active Treatment Sveta Marina EAD", Varna
Rabin Medical Center, Petah Tikva
Institutul Clinic Fundeni - Sectia Oncologie Medicala, Bucharest
Clinica Bendis - Oncologie Medicala, Cluj-Napoca
Centrul de Oncologie ONCOLAB, Craiova
Institutul Regional de Oncologie Iasi - Sectia Oncologie Medicala, Iași
Spitalul Pelican Impex SRL- Sectia Oncologie Medicala, Oradea
SC DACMED SRL - Oncologie, Ploieşti
Spitalului Clinic Judetean de Urgenta - Sectia Oncologie Medicala, Sibiu
"Spitalul Judetean de Urgenta Sf. Ioan Cel Nou - sectia Oncologie Medicala", Suceava
Vojnomedicinska Akademija Beograd, Belgrade
Institut za Onkologiju Vojvodine, Kamenitz
Zdravstveni Centar Kladovo Služba Onkologije, Kladovo
Klinički Centar Niš Klinika za Onkologiju, Niš
Lead Sponsor
Can-Fite BioPharma
INDUSTRY